Apremilast, an oral phosphodiesterase 4 inhibitor: Improvements in nail and scalp psoriasis and psoriasis area and severity index in patients with moderate to severe plaque psoriasis (ESTEEM 1 and 2)

Authors
Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2015
This article has no abstract
Epistemonikos ID: 192a998e6fdb8dd4c6c717178ec4fa46be5ada75
First added on: Feb 15, 2022